This topic contains a solution. Click here to go to the answer

Author Question: Symmetric key cryptography is also known as: A) public key cryptography. B) secret key ... (Read 43 times)

strangeaffliction

  • Hero Member
  • *****
  • Posts: 660
Symmetric key cryptography is also known as:
 
  A) public key cryptography.
  B) secret key cryptography.
  C) PGP.
  D) PKI.

Question 2

All the following statements about symmetric key cryptography are true except:
 
  A) in symmetric key cryptography, both the sender and the receiver use the same key to encrypt and decrypt a message.
  B) the Data Encryption Standard is a symmetric key encryption system.
  C) symmetric key cryptography is computationally slower.
  D) symmetric key cryptography is a key element in digital envelopes.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kalskdjl1212

  • Sr. Member
  • ****
  • Posts: 353
Answer to Question 1

B

Answer to Question 2

C




strangeaffliction

  • Member
  • Posts: 660
Reply 2 on: Jul 7, 2018
Excellent


adf223

  • Member
  • Posts: 304
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library